FDA Adverse Event Injury Summary report: N

FREESTYLE LIBRE

MDR report key: 7150067 · Received December 27, 2017

Report

Report Number
2954323-2017-09129
Event Type
Injury
Date Received
December 27, 2017
Date of Event
November 29, 2017
Report Date
April 12, 2019
Manufacturer
ABBOTT DIABETES CARE INC.
Product Code
PZE
PMA / PMN Number
P160030
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

SENSOR (B)(4) HAS BEEN RETURNED AND INVESTIGATED. VISUAL INSPECTION HAS BEEN PERFORMED AND NO ISSUES WERE OBSERVED. EXTRACTED DATA FROM RETURNED SENSOR USING APPROVED SOFTWARE. SENSOR FOUND TO BE IN STATE 5 (INDICATING NORMAL TERMINATION). OBSERVED SENSOR PLUG WAS PROPERLY SEATED IN MOUNT. REMOVED THE SENSOR PLUG ASSEMBLY AND PERFORMED VISUAL INSPECTION. EXTENDED INVESTIGATION HAS ALSO BEEN PERFORMED. DOSE AUDIT REPORTS AND ENVIRONMENTAL MONITORING REPORTS, INCLUDING BIOBURDEN AND ENDOTOXIN TESTING, WERE REVIEWED FOR THE QUARTERLY PERIOD DURING WHICH EACH COMPLAINT UNIT WAS MANUFACTURED. NO ABNORMALITIES WERE FOUND, AND THE INVESTIGATION SHOWED ALL PROCESSES WERE EFFECTIVE. NO MALFUNCTION OR PRODUCT DEFICIENCY WAS IDENTIFIED.

Additional Manufacturer Narrative · 1

THE PRODUCT HAS BEEN REQUESTED BACK FOR AN INVESTIGATION. A FOLLOW-UP REPORT WILL BE SUBMITTED ONCE ADDITIONAL INFORMATION IS OBTAINED. THE DATE REPORTED IS THE DATE ABBOTT DIABETES CARE BECAME AWARE OF THE EVENT. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT DIABETES CARE HAS BEEN SUBMITTED.

Description of Event or Problem · 1

AN ALLERGIC REACTION WAS REPORTED WITH USE OF AN ADC FREESTYLE LIBRE SENSOR. CUSTOMER, WHO IS ALSO A DOCTOR, REPORTED THAT AFTER 3 DAYS OF WEARING THE SENSOR, HE EXPERIENCED SYMPTOMS DESCRIBED AS REDNESS AND ITCHING. CUSTOMER SELF-TREATED WITH MONOVO (MOMETASONE) CREAM, A PRESCRIPTION GRADE CORTICOSTEROID. THERE WAS NO REPORT OF DEATH OR PERMANENT INJURY ASSOCIATED WITH THIS EVENT.

Description of Event or Problem · 1

AN ALLERGIC REACTION WAS REPORTED WITH USE OF AN ADC FREESTYLE LIBRE SENSOR. CUSTOMER, WHO IS ALSO A DOCTOR, REPORTED THAT AFTER 3 DAYS OF WEARING THE SENSOR, HE EXPERIENCED SYMPTOMS DESCRIBED AS REDNESS AND ITCHING. CUSTOMER SELF-TREATED WITH MONOVO (MOMETASONE) CREAM, A PRESCRIPTION GRADE CORTICOSTEROID. THERE WAS NO REPORT OF DEATH OR PERMANENT INJURY ASSOCIATED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
927901 FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM PZE ABBOTT DIABETES CARE INC. 71702-01

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention